SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-021183
Filing Date
2023-05-11
Accepted
2023-05-11 16:00:58
Documents
14
Period of Report
2023-05-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evok-20230510.htm   iXBRL 8-K 115929
2 EX-10.1 evok-ex10_1.htm EX-10.1 376126
3 EX-10.2 evok-ex10_2.htm EX-10.2 185686
  Complete submission text file 0000950170-23-021183.txt   871110

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evok-20230510.xsd EX-101.SCH 2478
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evok-20230510_pre.xml EX-101.PRE 9459
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evok-20230510_lab.xml EX-101.LAB 12806
8 EXTRACTED XBRL INSTANCE DOCUMENT evok-20230510_htm.xml XML 4534
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 23910752
SIC: 2834 Pharmaceutical Preparations